Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
about
Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant TumoursMolecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxinIdentification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28Differential regulation of B7 mRNA in enterocytes and lymphoid cellsSuperantigens: mechanisms by which they may induce, exacerbate and control autoimmune diseases.Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production.Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host diseaseGene therapy: development of immunostimulatory treatments for cancer.PD-1 inhibits antiviral immunity at the effector phase in the liver.Kinetics of gene expression in murine cutaneous graft-versus-host disease.The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.Expression of costimulatory molecules in the bovine corpus luteum.Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2.IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo.Early signaling defects in human T cells anergized by T cell presentation of autoantigen.Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.Identification, by protein sequencing and gene transfection, of sgp-60 as the murine homologue of CD48.Extending the B7 (CD80) gene familyFas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking.Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10.Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide.B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient miceInduction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1Phenotypic and functional analysis of positive selection in the gamma/delta T cell lineagePeptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signalingCostimulator deficient antigen presentation by an endothelial cell line induces a nonproliferative T cell activation response without anergy.B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance.Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro.Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.A reassessment of the role of B7-1 expression in tumor rejection.A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaBCD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells.B7-2 expressed on EL4 lymphoma suppresses antitumor immunity by an interleukin 4-dependent mechanism.
P2860
Q21284986-D52EA2ED-66AB-45D4-A5B3-FDA0FCCE8961Q24310542-FB337FAD-6E82-471F-B80E-E25BDA29A56BQ28114978-6A3EE420-3859-4573-9838-F7170DDEDF05Q28288428-90B031BA-49C9-4850-8397-2AFB2CB1424BQ28507575-9BC41717-D2EB-4045-B30E-6193426FD092Q33805908-CA009804-9702-47E0-9739-1F519CB959D4Q33999989-5616AF64-F47B-4957-83F7-9D78E1156484Q34186352-8162C904-7D40-496A-A98C-4765B8FF794FQ34187915-019DC7EF-F848-4496-9D0B-0582AC9ADD4CQ34535179-36A55710-573E-406A-A1FD-3A33A16AD27EQ35098314-3D28910A-732F-4070-94E8-B6AC187ACAB2Q35604062-505C661E-35A1-4AC1-94D7-D69D157D02F8Q35642275-F77F8875-4949-4707-B3FA-93A320DA9D4DQ35745695-B5BC26EC-3A04-475D-BF54-D4D4DBDFCC75Q35950374-B6588F5F-0D96-429D-A713-4B82D5264D45Q36080721-55877A66-851A-49E5-BDD9-9F520801D03FQ36230770-BCD66758-C40B-46BF-A2B6-40BE3AF6DF13Q36231544-05D6CDA6-285E-40FF-9B40-7C8651557915Q36231905-B60C33BF-593E-4875-86AD-0D52D619D096Q36232150-82E57D7A-1456-49AD-BB41-D913FB152B57Q36243402-86AC8B9B-153E-4281-B10A-556B2DEBB81DQ36278785-C544932D-1D7E-4095-8989-F54AD82C1B61Q36285131-6B84B1F0-FB0E-4DF4-8734-C1B633AFD08AQ36292507-3A749C5E-334D-483A-9117-5E4111D074ADQ36297378-809C6E84-6F87-4CA0-AA63-E4BF26C54587Q36315467-29F860D0-A1BC-4A68-A3D4-D6A525842457Q36361179-B5647B66-3C41-4F38-96EB-37E286F7219CQ36361521-9C688905-16BD-4706-99EC-7422B2D81970Q36361605-9C52CD76-A84F-4084-A765-308EF3663B3EQ36362513-206EA2AD-4AD0-4E64-A7CF-9C74BC324330Q36362561-17880CDA-F877-4B6C-9FAF-096ACA72EC87Q36362788-A1B64EB7-D5E5-4945-953F-F8B6D4C653A9Q36363106-4D24E5A0-4712-49F3-8676-F0C3E99F97B3Q36363597-5F70CB19-0BBE-4350-BE59-9CDAE380FF1AQ36363984-F3CFEF13-95B8-48BA-A0AE-5C0566D47755Q36364745-87D22A86-5D72-45B4-96B6-030097723565Q36365375-B10F81FF-7D92-4CC3-9044-075B73D34596Q36365928-FAB8BA02-9C19-4682-8255-90AC6E111667Q36366075-D00507A7-CFF3-4562-80E4-1F00E0983490Q36368136-4AA18032-CF4E-494E-AC33-E5D71CF2E62E
P2860
Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
description
1991 nî lūn-bûn
@nan
1991 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Structure, expression, and T c ...... mphocyte activation antigen B7
@ast
Structure, expression, and T c ...... mphocyte activation antigen B7
@en
Structure, expression, and T c ...... mphocyte activation antigen B7
@nl
type
label
Structure, expression, and T c ...... mphocyte activation antigen B7
@ast
Structure, expression, and T c ...... mphocyte activation antigen B7
@en
Structure, expression, and T c ...... mphocyte activation antigen B7
@nl
prefLabel
Structure, expression, and T c ...... mphocyte activation antigen B7
@ast
Structure, expression, and T c ...... mphocyte activation antigen B7
@en
Structure, expression, and T c ...... mphocyte activation antigen B7
@nl
P2093
P2860
P356
P1476
Structure, expression, and T c ...... mphocyte activation antigen B7
@en
P2093
G J Freeman
J D Fingeroth
J G Gribben
L M Nadler
P2860
P304
P356
10.1084/JEM.174.3.625
P407
P577
1991-09-01T00:00:00Z